Abstract
Abstract Major finding: CRAF has a direct role in mitosis that does not require the RAF effector MEK. Mechanism: CRAF interacts with PLK1 and promotes its activity and accumulation at kinetochores. Impact: Allosteric RAF inhibitors that block phospho-Ser338 CRAF may be effective cancer therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
